Authors : Dr. Harshita Guruprasad; Dr. Lakshmi Rachakonda; Dr. Shubhangi Mande
Volume/Issue : Volume 5 - 2020, Issue 9 - September
Google Scholar : http://bitly.ws/9nMw
Scribd : https://bit.ly/3l3rsuy
DOI : 10.38124/IJISRT20SEP584
A recent rise in the incidence of a vector borne
viral disease, Dengue Disease, in South Asian countries
has also shown an impact on the pregnant population in
these regions. There are four known Dengue virus
serotypes, the predominant ones being DENV- 2 and
DENV-3, when present during pregnancy could be
associated with complications like preterm birth,
maternal mortality and morbidity and adverse neonatal
outcomes.[1]. We aimed to study the outcomes in the
pregnant patients that presented to our institution with
the Dengue disease.
Methods:
A 6-month (1/9/2019 – 29/2/2020) study was
undertaken during the months of high prevalence of the
Dengue disease in our region. Clinical, laboratory,
maternal and foetal outcomes were studied among
serologically positive dengue mothers treated at MGM
Hospital, Aurangabad.
A total of 25 patients were found to have Dengue
disease during the study period. NS1Ag and IGM
serological analysis results were used to achieve
diagnosis and early management. 7 patients had
symptomatic thrombocytopenia and needed platelet
transfusions. Majority of our patients had favourable
outcomes. 3 mothers died succumbing to the multiorgan failure.
Favourable maternal and foetal outcomes could be
achieved with early diagnosis of suspected Dengue
disease with both NS1Ag and IGM serological analysis.
Keywords : Dengue in Pregnancy, Outcomes of Dengue Fever, Serological Markers in Dengue.